首页> 美国卫生研究院文献>Biochemia Medica >Peer-review policy and guidelines for Biochemia Medica Journal
【2h】

Peer-review policy and guidelines for Biochemia Medica Journal

机译:生化杂志同行评审政策和指南

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peer review is widely used system for evaluating manuscripts prior to publication. It has been and still is widely used tool for making justified and fair editorial decision. However, the evidence of its efficacy is limited and it has been criticized to be time-consuming, biased, inconsistent, conservative, and open to abuse. As a result, researchers, editors and policymakers have questioned its objectivity and purpose. Nevertheless, this should not be the reason for abandoning the principles of peer review, but to make the additional efforts towards its improvement. Therefore, this Research Integrity Corner aims to describe basic principles of peer review and to introduce Biochemia Medica’s guidelines for peer reviewers. Our intention is to help our peer reviewers provide evaluations that are as fair and objective as possible, while helping the journal publish innovative research of the highest quality.
机译:同行评审是发表之前评估稿件的广泛使用的系统。它已经并且仍然被广泛用于做出合理和公正的编辑决定的工具。但是,其功效的证据有限,并且被批评为耗时,有偏见,前后矛盾,保守且易于滥用。结果,研究人员,编辑和政策制定者对它的客观性和目的提出了质疑。但是,这不应成为放弃同行评审原则的原因,而应做出更多努力以改进同行评审。因此,本研究诚信角旨在描述同行评审的基本原则,并介绍《生化医学》给同行评审的指南。我们的意图是帮助我们的同行审稿人提供尽可能公正和客观的评估,同时帮助该期刊发表最高质量的创新研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号